Just to be clear - I don't think I've seen a worse looking chart. It's hard to argue anything other than dilution and dumping, except that the volume has not really been typical of a diluter.
but, again, these are not facts, just opinions.
For those who can't read, I'm not recommending anyone else buy it. I'm treating it as a bottom fish, possible turn-around candidate, for high risk funds. I like the concept but management has no clue how to build a strong shareholder base. Forget the fluff PR's and CD's, particularly if product is not available. Instead, they should Do some insider buying to show that they are in it with the shareholders.